Oncofetal MCB1 Is a Functional Biomarker for HCC Personalized Therapy
Sign Up to like & getrecommendations! Published in 2024 at "Advanced Science"
DOI: 10.1002/advs.202401228
Abstract: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer‐related death worldwide and lacks biomarkers for personalized therapy. Herein, it is reported that MCB1 could be a novel oncofetal protein that is upregulated in… read more here.
Keywords: therapy; hcc; personalized therapy; oncofetal mcb1 ... See more keywords